VJHemOnc Podcast
VJHemOnc Podcast

VJHemOnc Podcast

      |      

Подписчики

   Последние видео

iwAL 2023 Session II: Novel treatments in AML: FLT3 inhibitors, combinations, and more
28:07
iwAL 2023 Session I: Clonal hematopoiesis in AML, early detection and potential therapeutics
18:05
Applications of MRD in multiple myeloma: using MRD to guide treatment decisions
10:51
The importance of addressing racial disparities & differences in survival in patients with acute leukemias
16:52
Pre-MDS states: improving prognosis, novel therapeutic approaches, and challenges with distinguishing these conditions
10:05
Accelerated-phase MPNs: mutational landscape, challenges, and novel treatment strategies being explored
08:17
Determining the optimal sequencing of bispecifics and CAR-T cells in multiple myeloma
07:07
Overcoming barriers to CAR-T therapy: improving access and cost
11:27

Overcoming barriers to CAR-T therapy: improving access and cost
VJHemOnc Podcast
0 Просмотры · 2 лет тому назад

The importance of addressing quality of life and improving symptom management in MPNs
06:14
Hemophilia: the current standard of care and the value of novel gene therapies
06:47
CLL highlights at EHA 2023: latest advances with the use of BTK inhibitors
14:14
Myeloma highlights at EHA 2023: CARTITUDE-4 & CARTITUDE-1 updates & the use of MRD in clinical practice
08:24
Lymphoma highlights at EHA 2023: sequencing bispecifics & CAR-T cells, bridging therapy & toxicity management
16:48
The importance of genomic testing in CLL and its role in clinical decision-making
10:14
iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells
17:59
Key updates in CLL: novel treatment strategies, the changing role of chemotherapy, and more
11:35
iwAL 2022 Session IV: The evolving treatment landscape in ALL and the growing role of immunotherapies
16:02
iwNHL Session III: Exploring the optimal management of R/R follicular lymphoma in an expanding treatment landscape
11:22
Recent updates in CML: treatment strategies, clinical trials, and novel agents
15:43
iwNHL Session II: Understanding and harnessing the immune microenvironment against lymphoma
13:38
Показать больше